This inventor holds 1 USPTO granted patent. Top assignee: Health Research, Inc.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Pasha Apontes: Innovator in Cancer Biomarkers
Introduction
Pasha Apontes is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of personalized medicine, particularly in cancer treatment. His innovative work focuses on the analysis of specific biomarkers that can guide treatment decisions for patients.
Latest Patents
Pasha Apontes holds a patent titled "Methods for analysis of PDEF and survivin as interconnected cancer biomarkers and targets for personalized medicine." This patent outlines methods for determining whether an individual is a candidate to receive treatment with a DNA methylation inhibitor. The method can be performed on a biological sample of cancerous tissue from the individual. By determining that PDEF expression is absent or low and survivin expression is present, the individual can be identified as a candidate for this treatment. The method also includes the important step of communicating the results to a healthcare provider.
Career Highlights
Pasha Apontes is associated with Health Research, Inc., where he continues to advance research in cancer biomarkers. His work is pivotal in enhancing the understanding of how specific biomarkers can influence treatment options for cancer patients.
Collaborations
Pasha collaborates with talented individuals in his field, including Fengzhi Li and Ali Ghadersohi. Their combined expertise contributes to the ongoing research and development of innovative cancer treatment methods.
Conclusion
Pasha Apontes is a key figure in the realm of cancer research, with a focus on personalized medicine through innovative biomarker analysis. His contributions are vital for improving treatment strategies for cancer patients.